According to the US FDA, more than 70,000 patients had been treated with convalescent plasma. This week the agency granted Emergency Use Authorization for convalescent plasma to treat Covid-19. In a poll of 285 global Sermo physicians, 71% believe this EUA was justified.
While 73% support the FDA’s statement that “known and potential benefits of the product outweigh the known and potential risks of the product,” 78% also believe we don’t really have enough data to understand how effective convalescent plasma is. And 80% believe that to truly understand a treatment’s success, we need a randomized, placebo-controlled clinical trial that randomly chooses who gets the treatment and who doesn’t.
Regardless of the debate over the EUA, 93% believe that convalescent plasma could be potentially effective in treating Covid-19. Here’s more of what Sermo doctors have to say on this topic:
